NCT06708286View on ClinicalTrials.gov

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,820

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
DiphtheriaTetanusPertussis
Interventions
BIOLOGICAL

Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))

1 dose of Tdcp vaccine (0.5ml) on day 0

BIOLOGICAL

23-valent Pneumococcal Polysaccharide Vaccine (PPV23)

1 dose of PPV23 vaccine (0.5ml) on day 0

BIOLOGICAL

Tdcp

1 dose of Tdcp vaccine (0.5ml) on day 0

BIOLOGICAL

PPV23

1 dose of PPV23 vaccine (0.5ml) on day 0

BIOLOGICAL

Tdcp

1 dose of Tdcp vaccine (0.5ml) on day 0

BIOLOGICAL

PPV23

1 dose of PPV23 vaccine (0.5ml) on day 0

BIOLOGICAL

Tdcp

1 dose of Tdcp vaccine (0.5ml) on day 0

BIOLOGICAL

PPV23

1 dose of PPV23 vaccine (0.5ml) on day 0

BIOLOGICAL

Tdcp

1 dose of Tdcp vaccine (0.5ml) on day 0

BIOLOGICAL

Diphtheria-tetanus-acellular pertussis vaccine (DTaP)

1 dose of DTaP vaccine (0.5ml) on day 0

Trial Locations (1)

Unknown

Kaihua County Center for Disease Control and Prevention, Kaihua

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT06708286 - A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) | Biotech Hunter | Biotech Hunter